Drug targeting in antiviral chemotherapy
- 1 March 1986
- journal article
- research article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 35 (6) , 967-972
- https://doi.org/10.1016/0006-2952(86)90084-5
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Selective penetration and pharmacological activity of lactosaminated albumin conjugates of adenine arabinoside 5-monophosphate (ara-AMP) in mouse liver.Gut, 1984
- Antiviral treatment of chronic hepatitis B virus infection: pharmacokinetics and side effects of interferon and adenine arabinoside alone and in combinationAntimicrobial Agents and Chemotherapy, 1982
- Hepatocyte targeting of adenine‐9‐β‐D‐arabinofuranoside 5′‐monophosphate (ara‐AMP) coupled to lactosaminated albuminFEBS Letters, 1981
- Adenine arabinoside therapy in HBsAg-positive chronic liver disease: A controlled studyGastroenterology, 1981
- VidarabineDrugs, 1980
- Selective inhibition of ectromelia virus DNA synthesis in hepatocytes by adenine‐9‐β‐D‐arabinofuranoside (ara‐A) and adenine‐9‐β‐D‐arabinofuranoside 5′‐monophosphate (ara‐AMP) conjugated to asialofetuinFEBS Letters, 1980
- Effects of Interferon and Adenine Arabinoside Treatment of Hepatitis B Virus Infection on Cellular Immune ResponsesAntimicrobial Agents and Chemotherapy, 1979
- Toxicity of VidarabinePublished by American Medical Association (AMA) ,1979
- HBsAg-positive chronic liver disease: inhibition of DNA polymerase activity by vidarabine.BMJ, 1978
- Activity of albumin conjugates of 5-fluorodeoxyuridine and cytosine arabinoside on poxviruses as a lysosomotropic approach to antiviral chemotherapyNature, 1976